Gwendolyn Binder-Scholl
Technik-/Wissenschafts-/F&E-Leiter bei CABALETTA BIO, INC.
Vermögen: 243 600 $ am 30.04.2024
Aktive Positionen von Gwendolyn Binder-Scholl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CABALETTA BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2019 | - |
| INSTIL BIO, INC. | Direktor/Vorstandsmitglied | 01.07.2020 | - |
| Independent Dir/Board Member | 01.07.2020 | - |
Karriereverlauf von Gwendolyn Binder-Scholl
Ehemalige bekannte Positionen von Gwendolyn Binder-Scholl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2016 | 31.01.2019 |
| Corporate Officer/Principal | 01.03.2011 | 01.02.2016 | |
| University of Pennsylvania | Corporate Officer/Principal | 01.01.2006 | 01.01.2011 |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.01.2002 | 01.01.2005 |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Corporate Officer/Principal | - | - |
Ausbildung von Gwendolyn Binder-Scholl
| Wells College | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| CABALETTA BIO, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Adaptimmune LLC
Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Health Services |
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
- Börse
- Insiders
- Gwendolyn Binder-Scholl
- Erfahrung
